A type III effector antagonizes death receptor signalling during bacterial gut infection
Details
Publication Year 2013-09-12, Volume 501, Issue #7466, Page 247-251
Journal Title
NATURE
Publication Type
Journal Article
Abstract
Successful infection by enteric bacterial pathogens depends on the ability of the bacteria to colonize the gut, replicate in host tissues and disseminate to other hosts. Pathogens such as Salmonella, Shigella and enteropathogenic and enterohaemorrhagic (EPEC and EHEC, respectively) Escherichia coli use a type III secretion system(T3SS) to deliver virulence effector proteins into host cells during infection that promote colonization and interfere with antimicrobial host responses(1-3). Here we report that the T3SS effector NleB1 from EPEC binds to host cell death-domain-containing proteins and thereby inhibits death receptor signalling. Protein interaction studies identified FADD, TRADD and RIPK1 as binding partners of NleB1. NleB1 expressed ectopically or injected by the bacterial T3SS prevented Fas ligand or TNF-induced formation of the canonical death-inducing signalling complex (DISC) and proteolytic activation of caspase-8, an essential step in death-receptor-induced apoptosis. This inhibition depended on the N-acetylglucosamine transferase activity of NleB1, which specifically modified Arg 117 in the death domain of FADD. The importance of the death receptor apoptotic pathway to host defence was demonstrated using mice deficient in the FAS signalling pathway, which showed delayed clearance of the EPEC-like mouse pathogen Citrobacter rodentium and reversion to virulence of an nleB mutant. The activity of NleB suggests that EPEC and other attaching and effacing pathogens antagonize death-receptor-induced apoptosis of infected cells, thereby blocking a major antimicrobial host response.
Publisher
NATURE PUBLISHING GROUP
Keywords
CITROBACTER-RODENTIUM; INDUCED APOPTOSIS; DISEASE; VIRULENCE; PROTEINS; SYSTEM; ROLES; NLEB
WEHI Research Division(s)
Cell Signalling And Cell Death; Molecular Genetics Of Cancer
Rights Notice
© 2013 Macmillan Publishers Limited. All Rights Reserved. Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms


Creation Date: 2013-09-12 12:00:00
Last Modified: 0001-01-01 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙